International Stem Cell CORP (ISCO) stock
ISCOOTCPharmaceutical PreparationsFiscal year ends December 31
$0.28+0.00 (+0.89%)
Close on Oct 19, 2026Market cap $2.27MP/E –Yield –
International Stem Cell gross margin
Gross margin is gross profit as a percentage of revenue.
International Stem Cell's gross margin for the twelve months ending Jun 30, 2026 was 55.0%. For fiscal 2025 it was 55.7%, against 58.6% the year before. The highest annual figure on record is 73.3% in fiscal 2013.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 55.7% | −2.9 |
| FY2024 | Dec 31, 2024 | 58.6% | −0.6 |
| FY2023 | Dec 31, 2023 | 59.2% | −0.9 |
| FY2022 | Dec 31, 2022 | 60.0% | +0.9 |
| FY2021 | Dec 31, 2021 | 59.1% | −1.9 |
| FY2020 | Dec 31, 2020 | 61.0% | +2.5 |
| FY2019 | Dec 31, 2019 | 58.5% | −4.8 |
| FY2018 | Dec 31, 2018 | 63.3% | −8.2 |
| FY2017 | Dec 31, 2017 | 71.5% | −1.3 |
| FY2016 | Dec 31, 2016 | 72.9% | +0.1 |
| FY2015 | Dec 31, 2015 | 72.8% | +0.1 |
| FY2014 | Dec 31, 2014 | 72.6% | −0.6 |
| FY2013 | Dec 31, 2013 | 73.3% | +1.1 |
| FY2012 | Dec 31, 2012 | 72.1% | +7.8 |
| FY2011 | Dec 31, 2011 | 64.3% | +10.5 |
| FY2010 | Dec 31, 2010 | 53.8% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 54.5% | −7.6 |
| Q1 FY2026 | Mar 31, 2026 | 58.8% | +5.4 |
| Q4 FY2025 | Dec 31, 2025 | 50.5% | −9.0 |
| Q3 FY2025 | Sep 30, 2025 | 55.8% | +0.5 |
| Q2 FY2025 | Jun 30, 2025 | 62.1% | +1.3 |
| Q1 FY2025 | Mar 31, 2025 | 53.4% | −4.9 |
| Q4 FY2024 | Dec 31, 2024 | 59.5% | +5.2 |
| Q3 FY2024 | Sep 30, 2024 | 55.3% | −5.1 |
| Q2 FY2024 | Jun 30, 2024 | 60.8% | −0.4 |
| Q1 FY2024 | Mar 31, 2024 | 58.3% | −2.2 |
| Q4 FY2023 | Dec 31, 2023 | 54.3% | +1.1 |
| Q3 FY2023 | Sep 30, 2023 | 60.4% | +0.9 |
| Q2 FY2023 | Jun 30, 2023 | 61.3% | −3.3 |
| Q1 FY2023 | Mar 31, 2023 | 60.5% | −3.6 |
| Q4 FY2022 | Dec 31, 2022 | 53.3% | −4.7 |
| Q3 FY2022 | Sep 30, 2022 | 59.5% | −3.4 |
| Q2 FY2022 | Jun 30, 2022 | 64.6% | +8.1 |
| Q1 FY2022 | Mar 31, 2022 | 64.1% | +2.1 |
| Q2 FY2021 | Jun 30, 2021 | 58.0% | −2.3 |
| Q1 FY2021 | Mar 31, 2021 | 62.9% | −0.8 |
| Q4 FY2020 | Dec 31, 2020 | 56.4% | +7.1 |
| Q3 FY2020 | Sep 30, 2020 | 62.0% | +0.1 |
| Q2 FY2020 | Jun 30, 2020 | 60.3% | −2.8 |
| Q1 FY2020 | Mar 31, 2020 | 63.7% | +1.6 |
| Q4 FY2019 | Dec 31, 2019 | 49.4% | −13.1 |
| Q3 FY2019 | Sep 30, 2019 | 61.9% | +3.0 |
| Q2 FY2019 | Jun 30, 2019 | 63.1% | −0.9 |
| Q1 FY2019 | Mar 31, 2019 | 62.1% | −6.6 |
| Q4 FY2018 | Dec 31, 2018 | 62.5% | −3.6 |
| Q3 FY2018 | Sep 30, 2018 | 58.8% | −15.5 |
| Q2 FY2018 | Jun 30, 2018 | 64.0% | −9.3 |
| Q1 FY2018 | Mar 31, 2018 | 68.7% | −3.8 |
| Q4 FY2017 | Dec 31, 2017 | 66.1% | −7.0 |
| Q3 FY2017 | Sep 30, 2017 | 74.3% | +5.5 |
| Q2 FY2017 | Jun 30, 2017 | 73.3% | −0.3 |
| Q1 FY2017 | Mar 31, 2017 | 72.4% | – |
| Q4 FY2016 | Dec 31, 2016 | 73.1% | – |
| Q3 FY2016 | Sep 30, 2016 | 68.8% | – |
| Q2 FY2016 | Jun 30, 2016 | 73.6% | – |
See a number that looks wrong?